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Extra-adrenal paragangliomas are neoplasms of the para-
ganglia located within the paravertebral sympathetic and
parasympathetic chains. Thus paragangliomas may arise
anywhere along these tracts and common sites of occur-
rence include abdomen, retroperitoneum, chest and medi-
astinum and various head and neck locations such as
jugulotympanic membrane, orbit, nasopharynx, larynx,
vagal body and carotid body. Recent literature suggests a
molecular basis for the development of some paragan-
gliomas, i.e. germline mutations. Six genes have been
identified and are thought to contribute to the development
of pheochromocytoma/paraganglioma. These include RET,
VHL, NF1 and SDH subunits SDHB, SDHC, and SDHD.
SDHD and SDHB mutations account for a significant
percentage of head and neck paragangliomas. It is well
know that paragangliomas may be hereditary and may be
part of genetic syndromes such as Von Hippel-Lindau
syndrome, neurofibromatosis type I (von Recklinghausen
disease), MEN 2A and MEN 2B. When features of these
more commonly known syndromes are not present, many
familial cases, often associated with the above mentioned
germline mutations, go unrecognized.
In the head and neck region the normal paraganglia are
associated with the parasympathetic nervous system and
paragangliomas arising from these parasympathetic sites
account for up to 70% of extra-adrenal paragangliomas.
The most common site is the carotid body. Carotid body
paragangliomas arise at the bifurcation of the internal and
external carotid arteries and have classic radiographic
features.
Carotid body paragangliomas are vascular lesions, and
this is reflected in their imaging appearance. These lesions
splay apart the internal (ICA) and external carotid arteries
(ECA), and as it enlarges, it will encase, but not narrow the
ICA and ECA. Upon contrast administration the lesions
avidly enhance reflecting their vascular nature. Flow voids
from the numerous vessels are typically seen on MR
imaging, and this finding is part of the classic ‘‘salt and
pepper’’ imaging appearance of these lesions seen on T2
weighted images. The ‘‘pepper’’ refers to the low signal
flow voids, and the ‘‘salt’’ refers to high signal foci of
hemorrhage and/or slow flow. The lesions tend to be iso-
intense relative to muscle on T1 weighted imaging and
hyperintense on T2. Avid enhancement is seen on post-
contrast imaging (Fig. 1a, b). Cather angiography and CT
angiography reveal a hypervascular mass (Fig. 2) with
enlarged feeding arteries (typically the ascending pharyn-
geal or ascending cervical artery), intense tumor blush and
early draining veins. Indium-111 octreotide, which is a
somatostatin analog, is nuclear medicine imaging study
that is useful in the evaluation of paragangliomas, since
these are neuroendocrine neoplasms that have surface
receptors for somatostatin. A focal area of early intense
radiotracer uptake will be seen in the region of the para-
ganglioma (Fig. 3), and is sensitive for detecting tumors
greater than 1.5 cm. Octreotide scanning is useful for
detecting the presence of multicentric or metastatic
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paragangliomas, and for distinguishing scar from residual
tumor after surgery.
Surgical resection is the treatment of choice, but these
neoplasms are very vascular making resection challenging.
A surgical classification system was developed by Sham-
blin et al. in order to better predict surgical morbidity,
which is related to the relationship of the tumor with the
carotid vessels. The Shamblin classification divides the
tumors into three groups based on operative notes and
gross examination. Group 1 tumors are minimally attached
to vessels and easily removed. Group 2 lesions partially
surround the vessels and are more adherent to the
Fig. 1 a Axial T2 weighted
image demonstrates punctuate
areas of low signal consistent
with flow voids (arrow). b The
post contrast T1 weighted image
demonstrates avid contrast
enhancement
Fig. 2 Sagittal reformation from a CT angiogram demonstrates
intense enhancement at the left carotid bifurcation with splaying of
the internal and external carotid arteries
Fig. 3 Indium-111 octreotide scan demonstrates avid uptake of
radiotracer in the region of the left carotid bifurcation on the 4 h delay
scan
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adventitia, and group 3 lesions were adherent to the entire
surface of the carotid bifurcation making surgical resection
impossible. Arya et al. demonstrated that preoperative MR
imaging can predict the Shamblin group based on the
degree of circumferential contact of the paraganglioma
with the internal carotid artery on axial imaging.
On gross examination the tumors are usually well-cir-
cumscribed and may have a pseudocapusle. The cut surface
is typically solid with a smooth, rubbery texture but may
display some areas of hemorrhage. The actual size of the
tumors may vary greatly. Some have reported tumors as
large as 10 cm. Paragangliomas that are found in difficult
to access locations such as jugulotympanic paragangliomas
more often will be fragmented and histologic features may
be difficult to decipher. Histologically, carotid body
tumors, and paragangliomas in general, have a character-
istic growth pattern often referred to as a ‘‘zellballen’’
growth pattern. This refers to a well-developed nested or
organoid growth pattern of the tumor cells with an inter-
vening stromal component of delicate fibrovascular tissue
and supporting cells or ‘‘sustentacular’’ cells at the
periphery of the zellballen or cell nests. The tumor cells
(i.e. paraganglioma cells) are predominantly chief cells
with round, hyperchromatic nuclei, a dispersed chromatin
and abundant granular cytoplasm which may range from
eosinophilic to basophilic in color (Fig. 4). Occasionally
neuromelanin pigment may be seen and amyloid deposition
has also been described. Like the pheochromocytes of
adrenal pheochromocytomas, the tumor cells show reac-
tivity with chromogranin and synaptophysin stains by
immunohistochemical techniques (Fig. 5a) along with
other markers of neuroendocrine differentiation such as
CD56 and neuron specific enolase. The sustentacular cell
population can usually be identified at the periphery of the
nests and are thought to be modified Schwann cells; they
are spindle shaped and can be highlighted with S-100
protein staining (Fig. 5b).
Carotid body tumors and paragangliomas of the head
and neck are typically painless, slow growing tumors that
are often present for years prior to the patient seeking
medical attention. They may attain large size and infiltra-
tive growth and local recurrence may lead to death.
Although it is estimated that less than 10% of paragan-
gliomas are malignant, in some studies malignancy rates
are as high as 50%. It is important to remember that all
have malignant potential and it is not always possible to
predict malignant behavior based on histologic features
alone. There are some studies that have undertaken the task
of identifying histologic criteria for malignancy, some of
which are helpful, but further studies need to be performed.
Some worrisome histologic features include necrosis,
extensive capsular or vascular invasion, increased mitotic
activity, atypical mitotic figures, loss of a well-differenti-
ated zellballen pattern with loss of the S-100 positive
sustentacular cell population and tumor cell spindling. At
this point however there are no definitive, well-accepted,
Fig. 4 High power hematoxylin and eosin (H&E) stain showing a
well-developed ‘‘zellballen’’ growth pattern. The neoplastic cells
demonstrate a basophilic granular cytoplasm and round hyperchro-
matic nuclei with dispersed chromatin
Fig. 5 a Strong reactivity with chromogranin staining by immuno-
histochemical technique is shown. b The sutentacular cell population
at the periphery of the cell nests (‘‘zellballen’’) is highlighted by
S-100 protein immunohistochemical staining
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reproducible histologic criteria for malignancy in extra-
adrenal paraganglioma.
The differential diagnosis of head and neck paragan-
gliomas depends greatly on the actual location of the
lesion. The differential diagnoses in tumors arising in the
jugulotympanic area include middle ear adenoma, menin-
gioma, and schwannoma, among others. The tumors in this
location may be quite fragmented and histologic differen-
tiation may be quite difficult and immunohistochemistry
often plays a big role. In carotid body tumors the histologic
features are more readily identified and the differential
diagnosis includes other neuroendocrine tumors such as
medullary thyroid carcinoma and neuroendocrine carci-
noma. Hyalinizing trabecular adenoma of the thyroid gland
should also be considered but typically does not display
neuroendocrine features on immunohistochemistry.
The treatment of choice for carotid body tumor para-
gangliomas is surgical resection. Pre-operative adrenergic
blockade should be considered and due to the high vas-
cularity of these tumors pre-operative embolization is
prudent. Overall prognosis is quite good with complete
surgical resection. Continued follow-up is necessary,
however, as recurrence and metastasis may occur years
later. It is estimated that malignant paragangliomas have
less than a 50% 10 year survival rate. Surgery remains the
treatment choice for these malignant tumors since che-
motherapy and radiation do not appear to be of significant
benefit.
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